CD274 and head and neck squamous cell carcinoma: Given the number of other known regulatory pathways active in the TME and systemically, plus undoubtedly unknown unknowns, the failure to identify a really specific measure of PD-L1 expression for very accurate prognostics and treatment deployment in HNSCC (OPSCC) is probably understandable.